Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer
Wake Forest University Health Sciences
Wake Forest University Health Sciences
National Cancer Institute (NCI)
Merus B.V.
National Cancer Institute (NCI)
Boehringer Ingelheim
Stanford University
National Cancer Institute (NCI)
University of Edinburgh
Ensem Therapeutics
AstraZeneca
National Cancer Institute (NCI)
Johnson & Johnson Enterprise Innovation Inc.
University of Erlangen-Nürnberg Medical School
Johnson & Johnson Enterprise Innovation Inc.
Exelixis
Mayo Clinic
University of California, Davis
University of Erlangen-Nürnberg Medical School
Kivu Bioscience Inc.
AstraZeneca
University Health Network, Toronto
University Health Network, Toronto
Case Comprehensive Cancer Center
Bicara Therapeutics
STORM Therapeutics LTD
Tempus AI
Emory University
Alliance for Clinical Trials in Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Tubulis GmbH
Second Affiliated Hospital, School of Medicine, Zhejiang University
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Eli Lilly and Company
Neonc Technologies, Inc.
Universität des Saarlandes
Dana-Farber Cancer Institute
Ipsen
Sumitomo Pharma America, Inc.
Terremoto Biosciences Inc.
Bristol-Myers Squibb
University of Pisa
National Taiwan University Hospital
Seagen Inc.
Merus B.V.
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Radiopharm Theranostics, Ltd
Memorial Sloan Kettering Cancer Center
Tizona Therapeutics, Inc